Biologic medications treat a wide range of diseases, including autoimmune disorders, cancer, and some genetic conditions. A “biosimilar” medication is a drug that is very close to an original biologic medication, also called its “reference biologic.” Although not identical, the FDA reviews each biosimilar to ensure it works the same way and is as safe and effective as its reference biologic. The main difference is that biosimilars may cost less.
Your Generations Advantage Part D formulary (list of covered drugs) includes some biosimilars. If you have been prescribed a reference biologic, talk with your doctor or pharmacist to see if a biosimilar is right for you.
Prescribed Reference Biologic | Coverage | Biosimilar Medication | Coverage |
---|---|---|---|
Actemra (tocilizumab) | Not covered | Tyenne (tocilizumab-aazg) | Tier 5 |
Avastin (bevacizumab) | Not covered | Zirabev (bevacizumab-bvzr) | Tier 5 |
Herceptin (trastuzumab) | Tier 5 | Kanjinti, Trazimera, Ontruzant, Herzuma, Ogivri | Tier 5 |
Humira (adalimumab) | Tier 5 | Idacio (adalimumab-aacf) | Tier 5 |
Neulasta (pegfilgrastim) | Not covered | Fulphila (pegfilgrastim-jmdb) | Tier 5 |
Neupogen (filgrastim) | Not covered | Zarxio (filgrastim-sndz) | Tier 5 |
Remicade (infliximab) | Tier 5 | Renflexis (infliximab-abda) | Tier 5 |
Rituxan (rituximab) | Not covered | Truxima (rituximab-abbs) | Tier 5 |
Learn more about biosimilars on the FDA website at http://fda.gov/drugs/biosimilars/biosimilars-basics-patients.